8주간의 저항성운동 및 열량 감소식이가 비만 중년 흰쥐의 Traf2- NFkB-mTOR 및 SIRT1-FoxO1 신호인자의 발현에 미치는 영향

키워드

참고문헌 (56)

1. Eckel RH, "Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the pathophysiology of obesity-associated cardiovascular disease", Circulation, 105(24), pp.2923~2928 (2002)
2. Levy D, "Prognostic implications of echocardio-graphically determined left ventricular mass in the Framingham Heart Study", N Eng J Med, 322(22), pp.1561~1566 (1990)
3. Li SY, "Cardiac contractile dysfunction in Lep", Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca2+-ATPase and myosin heavy chain isozyme switch, 2006, pp.49(6), 1434~1446
4. Sowers JR, "Obesity as a cardiovascular risk factor", Am J Med, 115, pp.37~41 (2003)
5. Feuvray D, "Diabetes-related metabolic perturbations in cardiac myocyte", Diabetes Metab, 34, pp.3~9 (2008)
6. Boudina S, "Mitochondrial uncoupling : a key contributor to reduced cardiac efficiency in diabetes", Physiology(Bethesda), 21, pp.250~258 (2006)
7. Dong F, "Metallothionein prevents high-fat diet induced cardiac contractile dysfunction : role of peroxisome proliferator activated receptor gamma coactivator1alpha and mitochondrial biogenesis", Diabetes, 56(9), pp.2201~2212 (2007)
8. Lima-Leopoldo AP, "Obesity induces upregulation of genes involved in myocardial Ca2+ handling", Braz J Med Biol Res, 41(7), pp.615~620 (2008)
9. Ouwens DM, "Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats", Diabetologia, 48(6), pp.1229~1237 (2005)
10. Smeets PJ, "Inflammatory pathways are activated during cardiomyocyte hypertrophy and attenuated by peroxisome proliferator-activated receptors PPARalpha and PPARdelta", J Biol Chem, 283(43), pp.29109~29118 (2008)
11. Thaik CM, "Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes", J Clin Invest, 96(2), pp.1093~1099 (1995)
12. Yokoyama T, "Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes", Circulation, 95(5), pp.1247~1252 (1997)
13. Jang KW, "Ubiquitin ligase CHIP induces TRAF2 proteasomal degradation and NF-kappaB inactivation to regulate breast cancer cell invasion", J Cell Biochem, 112(12), pp.3612~3620 (2011)
14. Zhang X, "TRAF2 regulates the cytoplasmic", nuclear distribution of TRAF4 and its biological function in breast cancer cells, 2013, pp.436(2), 344~348
15. Burchfield JS, "The cytoprotective effects of tumor necrosis factor are conveyed through tumor necrosis factor receptor-associated factor 2 in the heart", Circ Heart Fail, 3(1), pp.157~164 (2010)
16. Divakaran VG, "Tumor necrosis factor receptor-associated factor 2 signaling provokes adverse cardiac remodeling in the adult mammalian heart", Circ Heart Fail, 6(3), pp.535~543 (2013)
17. Wang CY, "Obesity increases vascular senescence and susceptibility to ischemic injury through chronic activation of Akt and mTOR", Sci Signal, 2(62), pp.ra11~ (2009)
18. Sciarretta S, "Markers of inflammation and fibrosis are related to cardiovascular damage in hypertensive patients with metabolic syndrome", Am J Hypertens, 20(7), pp.784~791 (2007)
19. Sciarretta S, "Rheb is a critical regulator of autophagy during myocardial ischemia : pathophysiological implications in obesity and metabolic syndrome", Circulation, 125(9), pp.1134~1146 (2012)
20. Sengupta A, "FoxO transcription factors promote autophagy in cardiomyocytes", J Biol Chem, 284(41), pp.28319~28331 (2009)
21. Gustafsson AB, "Recycle or die : the role of autophagy in cardioprotection", J Mol Cell Cardiol, 44(4), pp.654~661 (2008)
22. Nishida K, "The role of autophagy in the heart", Cell Death Differ, 16(1), pp.31~38 (2009)
23. Mammucari C, "FoxO3controls autophagy in skeletal muscle in vivo", Cell Metab, 6(6), pp.458~471 (2007)
24. Zhao J, "FoxO3 coordinately activates protein degradation by the autophagic", lysosomal and proteasomal pathways in atrophying muscle cells, 2007, pp.6(6), 472~483
25. Blinderman CD, "Symptom distress and quality of life in patients with advanced congestive heart failure", J Pain Symptom Manage, 35(6), pp.594~603 (2008)
26. Cowie MR, "Survival of patients with a new diagnosis of heart failure : a population based study", Heart, 83(5), pp.505~510 (2000)
27. Bleumink GS, "Quantifying the heart failure epidemic : prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study", Eur Heart J, 25(18), pp.1614~1619 (2004)
28. Pluim BM, "The athlete’s heart. A meta-analysis of cardiac structure and function", Circulation, 101(3), pp.336~344 (2000)
29. Eghbali M, "Molecular and functional signature of heart hypertrophy during pregnancy", Circ Res, 96(11), pp.1208~1216 (2005)
30. Zak R, "Cardiac hypertrophy : its characteristics as a growth process", Am J Cardiol, 44(5), pp.941~946 (1979)
31. Barboza CA, "Cardioprotective properties of aerobic and resistance training against myocardial infarction", Int J Sports Med, 37(6), pp.421~430 (2016)
32. Jung S, "The effect of ladder-climbing exercise on atrophy", hypertrophy-related myokine expression in middle-aged male Wistar rats, 2015, pp.65(6), 515~521
33. Kim JY, "High-fat diet- induced muscle insulin resistance: relationship to visceral fat mass", Am J Physiol Regul Integr Comp Physiol, 279(6), pp.R2057~2065 (2000)
34. Lowry OH, "Protein measurement with the Folin phenol reagent", J Biol Chem, 193(1), pp.265~275 (1951)
35. Yusuf S, "Obesity and the risk of myocardial infarction in 27, 000 participants from 52countries : a case-control study", Lancet, 366(9497), pp.1640~1649 (2005)
36. Bouhidel O, "Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob", ob mice, 2008, pp.295(4), H1580~1586
37. Ferdinandy P, "Interaction of cardiovascular risk factors with myocardial ischemia", reperfusion injury, preconditioning and post-conditioning, 2007, pp.59(4), 418~458
38. Peart JN, "Clinical cardioprotection and the value of conditioning responses", American journal of physiology. Am J Physiol Heart Circ Physiol, 296(6), pp.H1705~1720 (2009)
39. Huang Y, "Cardiac-specific Traf2overexpression enhances cardiac hypertrophy through activating AKT", GSK3β signaling, 2014, pp.536(2), 225~231
40. Ermolaeva MA, "Function of TRADD in tumor necrosis factor receptor1signaling and in TRIF-dependent inflammatory responses", Nature Immunol, 9(9), pp.1037~1046 (2008)
41. Jono H, "NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB : evidence for a novel inducible autoregulatory feedback pathway", J Biol Chem, 279(35), pp.36171~36174 (2004)
42. Tsang CK, "Targeting mammalian target of rapamycin(mTOR) for health and diseases", Drug Discov Today, 12(3-4), pp.112~124 (2007)
43. Wang C, "Rapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells", J Clin Invest, 123(4), pp.1677~1693 (2013)
44. Blair SN, "Effects of physical inactivity and obesity on morbidity and mortality: current evidence and research issues", Med Sci Sports Exerc, 31(11), pp.S646~662 (1999)
45. Savage PD, "Reduction in obesity and coronary risk factors after high caloric exercise training in overweight coronary patients", Am Heart J, 146(2), pp.317~323 (2003)
46. Golbidi S, "Molecular mechanisms in exercise-induced cardioprotection", Cardiol Res Pract, 2011, pp.972807~ (2011)
47. Cunningham JT, "mTOR controls mitochondrial oxidative function through a YY1-PGC-1α transcriptional complex", Nature, 450(7170), pp.736~740 (2007)
48. Chong ZZ, "Cardiovascular disease and mTOR signaling", Trends Cardiovasc Med, 21(5), pp.151~155 (2011)
49. Wagner C, "Ischemic post-conditioning reduces infarct size of the in vivo rat heart:role of PI3-K, mTOR, GSK-3β, and apoptosis", Mol Cell Biochem, 339(1-2), pp.135~147 (2010)
50. Pal R, "Src-dependent impairment of autophagy by oxidative stress in a mouse model of Duchenne muscular dystrophy", Nat Commun, 5, pp.4425~ (2014)
51. Jung CH, "ULK-Atg13-FIP200complexes mediate mTOR signaling to the autophagy machinery", Mol Biol Cell, 20(7), pp.1992~2003 (2009)
52. Qu H, "1, 25(OH)2D3 improves cardiac dysfunction, hypertrophy, and fibrosis through PARP1", SIRT1, Mol Nutr Food Res, pp.2017, 61(5)[DOI]
53. Xie X, "IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation", Proc Natl Acad Sci USA, 108(16), pp.6474~6479 (2011)
54. Kaipeng Jing, "Why is autophagy important in human diseases?", Experimental and Molecular Medicine, 44(2), pp.69~72 (2012), 생화학분자생물학회
55. Wang Y, "Autophagy regulates inflammation following oxidative injury in diabetes", Autophagy, 9(3), pp.272~277 (2013)
56. DeBosch B, "Akt2 regulates cardiac metabolism and cardiomyocyte survival", J Biol Chem, 281(43), pp.32841~32851 (2006)

관련 논문AI추천